Sichuan Hebang Biotechnology Co. Ltd. Class A

Sichuan Hebang Biotechnology Co. Ltd. Class A

SSSE:603077
1.98
CNY
+0.03
(+1.54%)
-0.04EPS
19.34BMarket Cap
Apr 27Next Earn
Sichuan Hebang Biotechnology Co. Ltd. Class A
SSE:603077
(Shanghai Stock Exchange)

Recent

price

1.98

P/E

ratio

- -

div

yld

0.85%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.36
0.41
0.34
0.26
0.34
0.38
0.44
0.55
0.66
0.69
0.62
1.18
1.5
1.01
1.03
0.9
0.71
Revenue per Share
0.04
0.09
0.07
0.01
0.1
0.03
0.04
0.06
0.04
0.06
- -
0.36
0.44
0.15
- -
-0.07
-0.02
Basic EPS, GAAP
-0.06
0.04
-0.03
-0.17
-0.08
-0.09
-0.01
-0.04
0.06
-0.06
0.02
0.17
0.2
-0.09
-0.08
-0.02
- -
Free Cash Flow per Basic Share
0.03
0.03
0.02
0.05
0.03
0.05
0.02
0.01
0.03
0.01
0.01
0.01
0.02
0.05
0.03
0.02
0.02
Dividend per Share
0.21
0.3
0.57
0.55
0.71
0.86
1.18
1.24
1.24
1.27
1.26
1.61
2.16
2.22
2.11
2.02
2.22
Book Value per Share
0.18
0.27
0.55
0.51
0.47
0.59
0.89
0.95
0.96
0.99
0.99
1.34
1.88
1.92
1.8
1.69
1.66
Tangible Book Value per Share
3,933
4,617
5,140
6,076
6,426
7,539
7,945
8,626
9,077
8,658
8,530
8,436
8,697
8,706
8,280
7,982
8,140
Basic Weighted Avg Shares
1,433
1,900
1,738
1,603
2,186
2,863
3,463
4,738
6,009
5,969
5,261
9,987
13,039
8,824
8,547
7,188
5,783
Sales/Revenue/Turnover
18.4
31.56
27.02
7.37
10.76
11.33
10.21
13.63
10.68
11.25
10.09
36.51
34.82
16.81
1.03
3.7
11.5
Operating Margin (%)
154
202
195
197
269
323
418
525
575
636
643
644
930
1,002
987
1,012
- -
Depreciation Expense
173
416
335
64
672
240
318
518
363
517
41
3,018
3,807
1,283
31
-536
-176
Net Income, GAAP
14.27
14.58
14.08
8.59
1.13
15.43
13.02
15.25
28.26
13.21
81.6
15.42
14.92
16.75
- -
- -
- -
Effective Tax Rate (%)
12.06
21.91
19.27
4.02
30.73
8.38
9.18
10.92
6.04
8.66
0.78
30.22
29.2
14.54
0.37
-7.46
-3.04
Profit Margin (%)
-417
-149
1,458
212
-1,567
-1,376
2,278
2,261
1,720
707
166
1,520
5,985
6,185
8,629
8,240
10,700
Working Capital
1,000
1,223
745
805
1,002
864
796
494
308
226
285
105
430
456
4,951
6,131
7,668
LT Debt
975
1,377
3,405
3,290
4,752
6,582
10,776
11,275
11,199
11,453
11,307
14,632
19,763
20,218
19,007
17,959
19,695
Total Equity
6.22
14
8.17
1.28
10.13
2.04
2.72
4.18
2.43
3.96
0.61
20.55
20.19
5.86
- -
- -
- -
Return on Invested Capital (%)
9.05
17.79
10.82
2.78
12.12
3.77
3.72
4.81
3.83
4.49
0.7
20.87
20.47
5.98
- -
- -
- -
Return on Capital (%)
21.3
35.4
14.01
1.92
16.71
4.35
3.8
4.83
3.31
4.66
0.37
23.78
22.82
6.63
0.16
-2.94
-0.92
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
2,110
1,546
1,487
LT Borrowings
6,943
7,262
7,651
LT Finance Leases
21
20
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8,832
8,832
8,832
Market Capitalization
24,817
20,490
19,342

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
12,470
13,144
13,434
Cash, Cash Equivalents & STI
6,816
7,245
7,477
Accounts Receivable, Net
810
647
730
Inventories
4,211
4,305
4,098
Total Current Liabilities
3,235
2,674
2,734
Payables & Accruals
- -
- -
- -
ST Debt
2,110
1,546
1,487
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.39%
11.05%
-5.51%
Free Cash Flow
8.28%
107.77%
-71.82%
Net Income, GAAP
534.57%
1,065.99%
-1,804.79%
Sales/Revenue/Turnover
14.11%
13.81%
-15.91%
Total Cash Common Dividend
17.66%
36.07%
-44.96%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,999
2,849
1,965
1,734
8,547
2025
1,726
2,195
- -
1,261
7,188
2026
1,388
1,500
1,634
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.02
- -
-0.02
- -
2025
- -
- -
- -
-0.08
-0.07
2026
0.02
0.03
0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
0.02
0.03
2025
- -
- -
- -
0.01
0.02
2026
- -
- -
- -
- -
- -
Business
Sichuan Hebang Biotechnology Corporation Limited is a China-based company primarily engaged in the manufacture and sale of chemical products, biotechnology, and new materials. The company’s core product portfolio includes biological pesticides, biological veterinary drugs, feed nutrients such as methionine products, alkali products including sodium carbonate (soda ash), ammonium chloride, liquid ammonia, and calcium carbonate, as well as chemical pesticides including glyphosate and diglyphosate. In addition, it produces various types of glass products such as original glass, smart glass, special glass, low-e coated glass, photovoltaic glass panels, photovoltaic glass back panels, modules, and photovoltaic packaging materials. The company also develops and operates salt mines and phosphate mines. It services both domestic and overseas markets primarily through three business segments: chemical industry, glass manufacturing, and photovoltaic industry. Founded in 2002 and headquartered in Leshan, Sichuan Province, China, the company employs over 5,300 personnel. In recent years, Sichuan Hebang Biotechnology has pursued an aggressive expansion strategy involving investments in increased production capacity, notably with a major project to build a 500,000-ton annual production capacity glyphosate facility representing a total investment of approximately 16.7 billion yuan. To finance this project, the company issued 4.6 billion yuan of convertible bonds listed on the Shanghai Stock Exchange in late 2024. Despite challenges including declining net income and inventory concerns, the company remains focused on expanding its chemical production base and continuing development in its existing business areas. However, in mid-2025, the company suspended investment in its 10GW silicon wafer project and halted research and development on float glass, indicating a strategic shift in certain operational priorities. It also maintains strategic investments including a recent significant stake in Avenira Limited to broaden its portfolio in related sectors. Sichuan Hebang operates primarily within the chemical manufacturing, agricultural biotechnology, feed additives, glass manufacturing, and photovoltaic materials industries. Its products serve agricultural sectors, animal nutrition and veterinary care markets, construction and energy-saving building materials segments, and renewable energy industries through photovoltaic solutions. The company holds manufacturing facilities across Sichuan Province, facilitating efficient production and strategic resource allocation. It continues to develop its biological pesticide and feed nutrient product lines while expanding its chemical and glass product offerings domestically and internationally. Sichuan Hebang Biotechnology Corporation Limited combines a diversified chemical product portfolio with advanced materials manufacturing and a strategic focus on biotechnology and sustainable energy, supported by ongoing investments in capacity expansion and targeted strategic partnerships to enhance its market position.